Veradigm Market Cap

Veradigm has a market cap or net worth of $828.83 million as of May 3, 2024. Its market cap has decreased by -56.33% in one year.

Market Cap

828.83M

Enterprise Value

n/a

1-Year Change

-56.33%

Ranking

n/a

Market Cap Chart

Since July 26, 1999, Veradigm's market cap has increased from $319.80M to $828.83M, an increase of 159.17%. That is a compound annual growth rate of 3.95%.

Market Cap History

Date	Market Cap	% Change
Feb 28, 2024	744.10M	-10.39%
Feb 27, 2024	830.40M	-8.54%
Feb 26, 2024	907.90M	0.48%
Feb 23, 2024	903.60M	-1.43%
Feb 22, 2024	916.70M	1.33%
Feb 21, 2024	904.70M	-0.95%
Feb 20, 2024	913.40M	1.08%
Feb 16, 2024	903.60M	-2.93%
Feb 15, 2024	930.90M	5.71%
Feb 14, 2024	880.60M	-2.43%
Feb 13, 2024	902.50M	-4.28%
Feb 12, 2024	942.90M	1.05%
Feb 9, 2024	933.10M	0.47%
Feb 8, 2024	928.70M	1.31%
Feb 7, 2024	916.70M	-6.36%
Feb 6, 2024	979.00M	-1.65%
Feb 5, 2024	995.40M	1.12%
Feb 2, 2024	984.40M	-2.07%
Feb 1, 2024	1.01B	0.77%
Jan 31, 2024	997.50M	-2.87%
Jan 30, 2024	1.03B	-2.69%
Jan 29, 2024	1.06B	2.77%
Jan 26, 2024	1.03B	0.20%
Jan 25, 2024	1.02B	-0.20%
Jan 24, 2024	1.03B	-0.43%

View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	698.52B
Novo Nordisk	566.57B
UnitedHealth Group	453.09B
Johnson & Johnson	359.71B
Merck & Co.	322.94B
AbbVie	290.01B
AstraZeneca	236.67B
Thermo Fisher	218.49B

Market Cap Rankings